How much revenue did Metabolic Explorer generate this year?
Metabolic Explorer has achieved a revenue of 198.79 M EUR this year.
Metabolic Explorer Revenue 2024
Metabolic Explorer Revenue
198.79 M EUR
Ticker
METEX.PA
ISIN
FR0004177046
WKN
A0MN12
In 2024, Metabolic Explorer's sales reached 198.79 M EUR, a 46.21% difference from the 135.96 M EUR sales recorded in the previous year.
The Metabolic Explorer Revenue history
| YEAR | REVENUE (undefined EUR) | GROSS MARGIN (%) |
|---|---|---|
| 2026e | 425.9 | -0,33 |
| 2025e | 260.59 | -0,54 |
| 2024e | 198.79 | -0,71 |
| 2023e | 135.96 | -1,04 |
| 2022 | 226.6 | -0,63 |
| 2021 | 169.69 | 9,44 |
| 2020 | 0.05 | -3324,00 |
| 2019 | 0.35 | -404,86 |
| 2018 | 3.31 | -42,84 |
| 2017 | 4.04 | -35,08 |
| 2016 | 1.92 | -73,84 |
| 2015 | 0.68 | -207,16 |
| 2014 | 3.74 | -37,87 |
| 2013 | 0.75 | -188,93 |
| 2012 | 2.1 | -67,48 |
| 2011 | 1.5 | -94,47 |
| 2010 | 1.46 | -97,05 |
| 2009 | 2.03 | -69,80 |
| 2008 | 3.58 | -39,58 |
| 2007 | 4.24 | -33,42 |
| 2006 | 3.9 | -36,33 |
| 2005 | 1.47 | -96,39 |
| 2004 | 0.18 | -787,22 |
Metabolic Explorer Revenue, EBIT, Net Income FR0004177046 · A0MN12
3 years
5 years
10 years
25 Years
Max
Revenue
EBIT
Net Income
Details
Revenue, EBIT and Profit
ⓘUnderstanding Revenue, EBIT, and Income
Gain insights into Metabolic Explorer, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Metabolic Explorer from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Metabolic Explorer’s net earnings, an ultimate measure of its financial health and profitability.
Yearly Analysis and Comparisons
Observe the yearly bars to understand the annual performance and growth of Metabolic Explorer. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
Utilizing Expectations for Investment
The expected values for the forthcoming years offer investors a glimpse into Metabolic Explorer’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Investment Insights
Leveraging the comparison between Revenue and EBIT helps in assessing Metabolic Explorer’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Metabolic Explorer’s growth potential.
Metabolic Explorer Revenue, EBIT and net profit per share
| Date | Metabolic Explorer Revenue | Metabolic Explorer EBIT | Metabolic Explorer Net Income |
|---|---|---|---|
| 2026e | 425.9 M undefined | 32.16 M undefined | 73.14 M undefined |
| 2025e | 260.59 M undefined | 7.21 M undefined | -4.72 M undefined |
| 2024e | 198.79 M undefined | -10.3 M undefined | -20.45 M undefined |
| 2023e | 135.96 M undefined | -31.93 M undefined | -43.01 M undefined |
| 2022 | 226.6 M undefined | -43.76 M undefined | -50.83 M undefined |
| 2021 | 169.69 M undefined | 73.04 M undefined | 82.62 M undefined |
| 2020 | 50,000 undefined | -9.65 M undefined | -8.93 M undefined |
| 2019 | 350,000 undefined | -8.38 M undefined | -8.25 M undefined |
| 2018 | 3.31 M undefined | -5.03 M undefined | -6.14 M undefined |
| 2017 | 4.04 M undefined | -11.1 M undefined | -11.27 M undefined |
| 2016 | 1.92 M undefined | 10.39 M undefined | 6.63 M undefined |
| 2015 | 684,000 undefined | -6.93 M undefined | -7.02 M undefined |
| 2014 | 3.74 M undefined | -3.79 M undefined | -3.75 M undefined |
| 2013 | 750,000 undefined | -4.05 M undefined | -3.88 M undefined |
| 2012 | 2.1 M undefined | -7.4 M undefined | -8.04 M undefined |
| 2011 | 1.5 M undefined | -5.86 M undefined | -3.41 M undefined |
| 2010 | 1.46 M undefined | -5.22 M undefined | -2.78 M undefined |
| 2009 | 2.03 M undefined | -3.78 M undefined | -1.63 M undefined |
| 2008 | 3.58 M undefined | -2.45 M undefined | -390,000 undefined |
| 2007 | 4.24 M undefined | -530,000 undefined | 1.68 M undefined |
| 2006 | 3.9 M undefined | 1.78 M undefined | 1.67 M undefined |
| 2005 | 1.47 M undefined | -2.25 M undefined | -2.09 M undefined |
| 2004 | 180,000 undefined | -1.11 M undefined | -640,000 undefined |
| Revenue | EBIT | Net Income | |
|---|---|---|---|
| 2004 | 180,000 EUR | -1.11 M EUR | -640,000 EUR |
| 2005 | 1.47 M EUR | -2.25 M EUR | -2.09 M EUR |
| 2006 | 3.9 M EUR | 1.78 M EUR | 1.67 M EUR |
| 2007 | 4.24 M EUR | -530,000 EUR | 1.68 M EUR |
| 2008 | 3.58 M EUR | -2.45 M EUR | -390,000 EUR |
| 2009 | 2.03 M EUR | -3.78 M EUR | -1.63 M EUR |
| 2010 | 1.46 M EUR | -5.22 M EUR | -2.78 M EUR |
| 2011 | 1.5 M EUR | -5.86 M EUR | -3.41 M EUR |
| 2012 | 2.1 M EUR | -7.4 M EUR | -8.04 M EUR |
| 2013 | 750,000 EUR | -4.05 M EUR | -3.88 M EUR |
| 2014 | 3.74 M EUR | -3.79 M EUR | -3.75 M EUR |
| 2015 | 684,000 EUR | -6.93 M EUR | -7.02 M EUR |
| 2016 | 1.92 M EUR | 10.39 M EUR | 6.63 M EUR |
| 2017 | 4.04 M EUR | -11.1 M EUR | -11.27 M EUR |
| 2018 | 3.31 M EUR | -5.03 M EUR | -6.14 M EUR |
| 2019 | 350,000 EUR | -8.38 M EUR | -8.25 M EUR |
| 2020 | 50,000 EUR | -9.65 M EUR | -8.93 M EUR |
| 2021 | 169.69 M EUR | 73.04 M EUR | 82.62 M EUR |
| 2022 | 226.6 M EUR | -43.76 M EUR | -50.83 M EUR |
| 2023e | 135.96 M EUR | -31.93 M EUR | -43.01 M EUR |
| 2024e | 198.79 M EUR | -10.3 M EUR | -20.45 M EUR |
| 2025e | 260.59 M EUR | 7.21 M EUR | -4.72 M EUR |
| 2026e | 425.9 M EUR | 32.16 M EUR | 73.14 M EUR |
Metabolic Explorer stock margins FR0004177046 · A0MN12
The Metabolic Explorer margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Metabolic Explorer. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Metabolic Explorer.
3 years
5 years
10 years
25 Years
Max
Gross margin
EBIT margin
Profit margin
Details
Margin
ⓘUnderstanding Gross Margin
The gross margin, expressed as a percentage, delineates the gross profit made from the Metabolic Explorer's sales revenue. A higher gross margin percentage indicates that the Metabolic Explorer retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT Margin Analysis
EBIT margin represents the Metabolic Explorer's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
Revenue Margin Insights
The revenue margin demonstrates the Metabolic Explorer's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Metabolic Explorer's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
Interpreting Expectations
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Metabolic Explorer. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparative Analysis
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Metabolic Explorer's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
Metabolic Explorer Margin History
| Metabolic Explorer Gross margin | Metabolic Explorer Profit margin | Metabolic Explorer EBIT margin | Metabolic Explorer Profit margin |
|---|---|---|---|
| 2026e | -0.63 % | 7.55 % | 17.17 % |
| 2025e | -0.63 % | 2.77 % | -1.81 % |
| 2024e | -0.63 % | -5.18 % | -10.29 % |
| 2023e | -0.63 % | -23.48 % | -31.63 % |
| 2022 | -0.63 % | -19.31 % | -22.43 % |
| 2021 | 9.44 % | 43.04 % | 48.69 % |
| 2020 | -3,324 % | -19,304 % | -17,864 % |
| 2019 | -0.63 % | -2,393.43 % | -2,355.71 % |
| 2018 | -0.63 % | -152.03 % | -185.49 % |
| 2017 | -0.63 % | -274.92 % | -279.08 % |
| 2016 | -0.63 % | 541.48 % | 345.34 % |
| 2015 | -0.63 % | -1,012.87 % | -1,026.17 % |
| 2014 | -0.63 % | -101.31 % | -100.13 % |
| 2013 | -0.63 % | -540 % | -517.33 % |
| 2012 | -0.63 % | -352.38 % | -382.86 % |
| 2011 | -0.63 % | -390.67 % | -227.33 % |
| 2010 | -0.63 % | -357.53 % | -190.41 % |
| 2009 | -0.63 % | -186.21 % | -80.3 % |
| 2008 | -0.63 % | -68.44 % | -10.89 % |
| 2007 | -0.63 % | -12.5 % | 39.62 % |
| 2006 | -0.63 % | 45.64 % | 42.82 % |
| 2005 | -0.63 % | -153.06 % | -142.18 % |
| 2004 | -0.63 % | -616.67 % | -355.56 % |
| Gross margin | EBIT margin | Profit margin | |
|---|---|---|---|
| 2004 | -0.63 % | -616.67 % | -355.56 % |
| 2005 | -0.63 % | -153.06 % | -142.18 % |
| 2006 | -0.63 % | 45.64 % | 42.82 % |
| 2007 | -0.63 % | -12.5 % | 39.62 % |
| 2008 | -0.63 % | -68.44 % | -10.89 % |
| 2009 | -0.63 % | -186.21 % | -80.3 % |
| 2010 | -0.63 % | -357.53 % | -190.41 % |
| 2011 | -0.63 % | -390.67 % | -227.33 % |
| 2012 | -0.63 % | -352.38 % | -382.86 % |
| 2013 | -0.63 % | -540 % | -517.33 % |
| 2014 | -0.63 % | -101.31 % | -100.13 % |
| 2015 | -0.63 % | -1,012.87 % | -1,026.17 % |
| 2016 | -0.63 % | 541.48 % | 345.34 % |
| 2017 | -0.63 % | -274.92 % | -279.08 % |
| 2018 | -0.63 % | -152.03 % | -185.49 % |
| 2019 | -0.63 % | -2,393.43 % | -2,355.71 % |
| 2020 | -3,324 % | -19,304 % | -17,864 % |
| 2021 | 9.44 % | 43.04 % | 48.69 % |
| 2022 | -0.63 % | -19.31 % | -22.43 % |
| 2023e | -0.63 % | -23.48 % | -31.63 % |
| 2024e | -0.63 % | -5.18 % | -10.29 % |
| 2025e | -0.63 % | 2.77 % | -1.81 % |
| 2026e | -0.63 % | 7.55 % | 17.17 % |
Metabolic Explorer Aktienanalyse
What does Metabolic Explorer do?
Metabolic Explorer SA is a French biotechnology company that was founded in 1999. It is headquartered in Clermont-Ferrand, France and employs approximately 70 employees, including scientists and engineers. The company specializes in the development and production of natural raw materials that are used in various industries such as cosmetics, food, and pharmaceuticals. The business model of Metabolic Explorer is based on innovative biological technology that enables the production of novel bio-based molecules by optimizing the metabolic processes of microorganisms. These novel molecules have higher quality and efficiency than conventional raw materials, making them promising alternatives for various industries. The company has specialized in various business areas. One of the most important is the production of bio-based amino acids used in the cosmetics and food industries. Metabolic Explorer has developed a patented method for producing amino acids from renewable resources such as plants and bacteria. This allows for amino acids to be produced without the use of petrochemical raw materials, making them more environmentally friendly and sustainable alternatives. Another business area of Metabolic Explorer is the production of bio-based lactic acid. Lactic acid is an important raw material for the production of bio-polymers, such as PLA (polylactic acid), used in the packaging industry. Again, Metabolic Explorer has developed a patented technology for producing lactic acid from renewable resources. Metabolic Explorer is also involved in the research and development of bio-molecules. The company works closely with various research institutions to optimize its biological technologies and processes and develop new applications. The goal is to improve the production of bio-based molecules and reduce costs. An example of Metabolic Explorer's innovative products is bio-based nylon precursor. Nylon is typically produced from petrochemical raw materials, leading to high costs and environmental impact. However, Metabolic Explorer has developed a patented technology that allows for the production of bio-based precursors that can be used as raw materials for nylon production. These bio-based precursors are made from renewable resources and can enable a more environmentally friendly and sustainable nylon. Metabolic Explorer has a variety of partnerships and collaborations with companies in various industries. One example is the collaboration with food company Roquette to develop bio-based glycerin products. Another partnership is with cosmetics company L'Oréal to develop bio-based lactic acid for use in cosmetics. Overall, Metabolic Explorer specializes in the development and production of bio-based molecules that offer a promising alternative to conventional petrochemical raw materials. With its patented biological technologies, the company is well-positioned to make a significant contribution to sustainability in various industries. Metabolic Explorer ist eines der beliebtesten Unternehmen auf Eulerpool.com.Revenue Details
Understanding Metabolic Explorer's Sales Figures
The sales figures of Metabolic Explorer originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.
Year-to-Year Comparison
Analyzing Metabolic Explorer’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.
Impact on Investments
Investors often scrutinize Metabolic Explorer's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.
Interpreting Sales Fluctuations
Increases in Metabolic Explorer’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.
Frequently Asked Questions about Metabolic Explorer stock
How much was the turnover of the company Metabolic Explorer compared to the previous year?
The revenue of Metabolic Explorer has increased by 46.21% increased compared to the previous year.
What does revenue mean for investors?
The revenue of a company is an important indicator of its financial performance and attractiveness for investors.
Which factors influence the revenue of Metabolic Explorer?
The revenue of Metabolic Explorer is influenced by various factors, including the demand for its products and services, market conditions, and prices.
How is the revenue of Metabolic Explorer measured?
Revenue is typically measured in units referring to the sale of goods and services provided by the company.
How does an increase in sales affect investments?
An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.
What are the possible risks associated with a declining revenue?
A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.
Why is the sales revenue of Metabolic Explorer so important for investors?
The revenue of Metabolic Explorer is an important indicator of financial performance and attractiveness for investors.
What strategic measures can a company take to increase revenue?
A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.
How much dividend does Metabolic Explorer pay?
Over the past 12 months, Metabolic Explorer paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Metabolic Explorer is expected to pay a dividend of 0 EUR.
What is the dividend yield of Metabolic Explorer?
The current dividend yield of Metabolic Explorer is .
When does Metabolic Explorer pay dividends?
Metabolic Explorer pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Metabolic Explorer?
Metabolic Explorer paid dividends every year for the past 0 years.
What is the dividend of Metabolic Explorer?
For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.
In which sector is Metabolic Explorer located?
Metabolic Explorer is assigned to the 'Commodities' sector.
Wann musste ich die Aktien von Metabolic Explorer kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Metabolic Explorer from 12/18/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 12/18/2024.
When did Metabolic Explorer pay the last dividend?
The last dividend was paid out on 12/18/2024.
What was the dividend of Metabolic Explorer in the year 2023?
In the year 2023, Metabolic Explorer distributed 0 EUR as dividends.
In which currency does Metabolic Explorer pay out the dividend?
The dividends of Metabolic Explorer are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Metabolic Explorer
Our stock analysis for Metabolic Explorer Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Metabolic Explorer Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- Metabolic Explorer Revenue
- Metabolic Explorer Net Income
- Metabolic Explorer P/E
- Metabolic Explorer P/S
- Metabolic Explorer EBIT
- Metabolic Explorer Dividend
- Metabolic Explorer Stocks
- Metabolic Explorer Market capitalization
- Metabolic Explorer Debt
- Metabolic Explorer Liabilities
- Metabolic Explorer Equity
- Metabolic Explorer AAQS
- Metabolic Explorer Employees
- Metabolic Explorer ROE
- Metabolic Explorer ROA
- Metabolic Explorer ROCE
